Thursday, March 30, 2017 10:41:23 AM
"The Company found that cannabidiol (CBD) universally inhibited cell growth at concentrations similar to established chemotherapeutics."
a general statement. has nothing to do with VBIO's product. also, no details on what research was done, under what conditions, etc.
"Vitality also found that its cannabidiol prodrug was not toxic to the human cells at the concentrations tested, demonstrating the relative safety of its prodrug delivery system.
and then a statement on its own drug, saying it is "relatively safe". whether it actually works isn't clear, as the first statement and the second statement seem to have no relation to each other.
and lets not forget, VBIO's "drug" (whatever that may be) needs to undergo three FDA-regulated phases, costing millions and millions and millions of dollars the company currently doesn't have, and years and years of research.
is VBIO actually interested in doing that, or are they in the business of sending out riduclous press releases with weird claims that are unsubstantiated and bear no actual significance to VBIO's own IP?
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM